Megan J Huchko1, Saduma Ibrahim2, Cinthia Blat3, Craig R Cohen3, Jennifer S Smith4, Robert A Hiatt5, Elizabeth Bukusi2,6,7. 1. Duke Global Health Institute, Duke University, Durham, NC, USA. 2. Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya. 3. Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA, USA. 4. Department of Epidemiology and Biostatistics, University of North Carolina, Chapel Hill, NC, USA. 5. Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. 6. Department of Obstetrics and Gynecology, Aga Khan University, Nairobi, Kenya. 7. Departments of Global Health and Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Abstract
OBJECTIVE: To determine the effectiveness of community health campaigns (CHCs) as a strategy for human papillomavirus (HPV)-based cervical cancer screening in rural western Kenya. METHODS: Between January and November 2016, a cluster-randomized trial was carried out in 12 communities in western Kenya to investigate high-risk HPV testing offered via self-collection to women aged 25-65 years in CHCs versus government health facilities. Outcome measures were the total number of women accessing cervical cancer screening and the proportion of HPV-positive women accessing treatment. RESULTS: In total, 4944 women underwent HPV-based cervical cancer screening in CHCs (n=2898) or health facilities (n=2046). Screening uptake as a proportion of total eligible women in the population was greater in communities assigned to CHCs (60.0% vs 37.0%, P<0.001). Rates of treatment acquisition were low in both arms (CHCs 39.2%; health facilities 31.5%; P=0.408). DISCUSSION: Cervical cancer screening using HPV testing of self-collected samples reached a larger proportion of women when offered through periodic CHCs compared with health facilities. The community-based model is a promising strategy for cervical cancer prevention. Lessons learned from this trial can be used to identify ways of maximizing the impact of such strategies through greater community participation and improved linkage to treatment. ClinicalTrials.gov registration: NCT02124252.
RCT Entities:
OBJECTIVE: To determine the effectiveness of community health campaigns (CHCs) as a strategy for human papillomavirus (HPV)-based cervical cancer screening in rural western Kenya. METHODS: Between January and November 2016, a cluster-randomized trial was carried out in 12 communities in western Kenya to investigate high-risk HPV testing offered via self-collection to women aged 25-65 years in CHCs versus government health facilities. Outcome measures were the total number of women accessing cervical cancer screening and the proportion of HPV-positive women accessing treatment. RESULTS: In total, 4944 women underwent HPV-based cervical cancer screening in CHCs (n=2898) or health facilities (n=2046). Screening uptake as a proportion of total eligible women in the population was greater in communities assigned to CHCs (60.0% vs 37.0%, P<0.001). Rates of treatment acquisition were low in both arms (CHCs 39.2%; health facilities 31.5%; P=0.408). DISCUSSION: Cervical cancer screening using HPV testing of self-collected samples reached a larger proportion of women when offered through periodic CHCs compared with health facilities. The community-based model is a promising strategy for cervical cancer prevention. Lessons learned from this trial can be used to identify ways of maximizing the impact of such strategies through greater community participation and improved linkage to treatment. ClinicalTrials.gov registration: NCT02124252.
Authors: Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin Journal: Int J Cancer Date: 2010-12-15 Impact factor: 7.396
Authors: Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman Journal: CA Cancer J Clin Date: 2011-02-04 Impact factor: 508.702
Authors: Eric Lugada; Debra Millar; John Haskew; Mark Grabowsky; Navneet Garg; Mikkel Vestergaard; James G Kahn; James G Khan; James Kahn; Nicholas Muraguri; Jonathan Mermin Journal: PLoS One Date: 2010-08-26 Impact factor: 3.240
Authors: Donna E Stewart; Anna Gagliardi; Mary Johnston; Robbi Howlett; Paula Barata; Nancy Lewis; Thomas Oliver; Verna Mai Journal: J Obstet Gynaecol Can Date: 2007-10
Authors: Gabriel Chamie; Tamara D Clark; Jane Kabami; Kevin Kadede; Emmanuel Ssemmondo; Rachel Steinfeld; Geoff Lavoy; Dalsone Kwarisiima; Norton Sang; Vivek Jain; Harsha Thirumurthy; Teri Liegler; Laura B Balzer; Maya L Petersen; Craig R Cohen; Elizabeth A Bukusi; Moses R Kamya; Diane V Havlir; Edwin D Charlebois Journal: Lancet HIV Date: 2016-01-26 Impact factor: 12.767
Authors: Omenge Orang'o; Philip Tonui; Kapten Muthoka; Stephen Kiptoo; Titus Maina; Mercy Agosa; Aaron Ermel; Yan Tong; Darron Brown Journal: SAGE Open Med Date: 2022-05-23
Authors: Yujung Choi; Saduma Ibrahim; Lawrence P Park; Craig R Cohen; Elizabeth A Bukusi; Megan J Huchko Journal: BMC Womens Health Date: 2022-04-18 Impact factor: 2.742
Authors: Felix Jede; Theresa Brandt; Molla Gedefaw; Solomon Berhe Wubneh; Tamrat Abebe; Brhanu Teka; Kassahun Alemu; Binyam Tilahun; Temesgen Azemeraw; Abebaw Gebeyehu; Dietmar Schmidt; Aleksandra Pesic; Andreas M Kaufmann; Bewketu Abebe; Zelalem Ayichew; Michael Byczkowski; Timoté Vaucher; Heike Sartor; Gashaw Andargie; Till Bärnighausen; Magnus von Knebel Doeberitz; Hermann Bussmann Journal: Papillomavirus Res Date: 2020-05-08